减重手术后糖尿病缓解预测模型的系统评价与荟萃分析
该系统评价检索了MEDLINE、Embase和CENTRAL等数据库近15年英文文献,共纳入38项研究(16项模型开发、22项验证)。在开发研究中,10个模型区分度优良(AUC≥0.800),其中ABCD和DiaRem模型在多种人群、手术方式和随访时长中获广泛外部验证,区分度可接受至优秀。
要点
- ABCD和DiaRem是外部验证最广泛的糖尿病缓解预测模型。
- 10个开发模型报告AUC≥0.800,但多数缺乏外部验证。
- 现有研究多为小样本、短随访,长期缓解预测证据不足。
核心结论
- 在已识别的预测模型中,ABCD和DiaRem模型验证最广泛,区分度可接受至优秀。
- 需要更多研究验证新模型并聚焦长期糖尿病缓解。
研究设计与样本
- 系统评价与荟萃分析,检索MEDLINE、MEDLINE In-Process、Embase和Cochrane CENTRAL,限近15年英文文献。
- 共纳入38项研究,包括16项模型开发研究和22项验证研究。
主要发现
- 16项开发研究中,11项开发评分系统,5项提出逻辑回归模型。
- 开发研究中10个模型AUC≥0.800,区分度优秀。
- ABCD和DiaRem在不同人群、多种减重手术方式和短期及长期缓解中获广泛外部验证。
- 较新模型在测试研究中区分度优秀,但外部验证有限。
关键数值与推荐
- 模型开发研究中,10个模型报告AUC≥0.800。
- 较新预测模型在测试研究中显示优秀区分度,但外部验证有限。
临床怎么用
- 临床可优先考虑使用ABCD或DiaRem模型预测减重术后糖尿病缓解。
- 对新模型的应用需谨慎,因其外部验证尚不充分。
局限性
- 很大比例的研究基于小样本队列且随访时间短。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Remission of type 2 diabetes following bariatric surgery is well established, but identifying patients who will go into remission is challenging. PURPOSE: To perform a systematic review of currently available diabetes remission prediction models, compare their performance, and evaluate their applicability in clinical settings. DATA SOURCES: A comprehensive systematic literature search of MEDLINE, MEDLINE In-Process & Other Non-Indexed Citations, Embase, and Cochrane Central Register of Controlled Trials (CENTRAL) was undertaken. The search was restricted to studies published in the last 15 years and in the English language. STUDY SELECTION: All studies developing or validating a prediction model for diabetes remission in adults after bariatric surgery were included. DATA EXTRACTION: The search identified 4,165 references, of which 38 were included for data extraction. We identified 16 model development and 22 validation studies. DATA SYNTHESIS: Of the 16 model development studies, 11 developed scoring systems and 5 proposed logistic regression models. In model development studies, 10 models showed excellent discrimination with area under the receiver operating characteristic curve ≥0.800. Two of these prediction models, ABCD and DiaRem, were widely externally validated in different populations, in a variety of bariatric procedures, and for both short- and long-term diabetes remission. Newer prediction models showed excellent discrimination in test studies, but external validation was limited. LIMITATIONS: While the key messages were consistent, a large proportion of the studies were conducted in small cohorts of patients with short duration of follow-up. CONCLUSIONS: Among the prediction models identified, the ABCD and DiaRem models were the most widely validated and showed acceptable to excellent discrimination. More studies validating newer models and focusing on long-term diabetes remission are needed.
引用
- Singh P, Adderley NJ, Hazlehurst J, et al. Prognostic Models for Predicting Remission of Diabetes Following Bariatric Surgery: A Systematic Review and Meta-analysis. Diabetes Care. 2021. PMID: 34670787. doi:10.2337/dc21-0166
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。